| Patent No. | Patent Title: |
| 5955432 | Metabolic effects of certain glutathione analogs |
| 5863742 | Inhibition of protease activity of human whole blood cell lysates |
| 5814611 | Pharmaceutical for the therapy of immune deficiency conditions |
| 5801225 | Sorbent families |
| 5795859 | Peptide which abrogates TNF and/or LPS toxicity |
| 5786336 | Target-selective protocols based on mimics |
| 5767086 | Bone marrow stimulation by certain glutathione analogs |
| 5767087 | Pharmaceutical preparation for the therapy of immune deficiency ... |
| 5763394 | Human growth hormone aqueous formulation |
| 5739272 | Procedure for obtaining carbocalcitonin |
| 5721212 | Peptides for heparin and low molecular weight heparin anticoagula... |
| 5716619 | Treatment of type 2 diabetes mellitus |
| 5716927 | Insulin analogs having a modified B-chain |
| 5714577 | Antimicrobial peptides |
| 5708016 | Pseudopeptides derived from neurokinins |
| 5705483 | Glucagon-like insulinotropic peptides, compositions and methods |
| 5696001 | Fluorogenic compounds and their use |
| 5693611 | Cyclic peptide antifungal agents |
| 5688527 | Lysine derivatives, process of preparation, uses, and composition... |
| 5688507 | Methods and compositions for inhibiting thrombogenesis |
| 5686417 | Peptide T and related peptides in the treatment of HTLV-1 myelopa... |
| 5686410 | Polypeptide derivatives |
| 5683907 | Metal ion-ligand coordination complexes, antibodies directed ther... |
| 5679349 | Vaccine design and production |
| 5680331 | Method and apparatus for mimicking protein active sites |
| 5679642 | Peptide-chelator conjugates |
| 5677283 | -heteroaryloxymethyl ketones as interleukin - 1 ଲ co... |
| 5674976 | Conformationally restricted mimetics of gamma turns and peptides ... |
| 5672681 | Conformationally restricted mimetics of gamma turns and peptides ... |
| 5670155 | Confomationally restricted mimetics of beta turns and beta bulges... |
| 5667784 | Tocols as adjuvant in vaccine |
| 5667992 | Mammalian expression systems for HCV proteins |
| 5668106 | Method and compositions for making ACSF and ACSF antagonists |
| 5665705 | Glucagon analogs with serine replacements |
| 5665860 | Human cancer inhibitory peptide amides |
| 5658878 | Therapeutic preparation for inhalation |
| 5656602 | PLA2 inhibitory compounds |
| 5648229 | Fluorogenic compounds and their use |
| 5646242 | Selective acylation of epsilon-amino groups |
| 5643868 | Method of treating or preventing type 1 diabetes by oral administ... |